Invisio - Weak Q2 but Positive Outlook for H2 22
2022-08-03 07:22:00
Redeye is updating its estimates and valuation of Invisio after the Q2 report, which came in weaker than expected due to higher costs for marketing activities. But the outlooks for H2 22 remain positive, with a record-high order book and steadily rising market activity.
(THIS IS A TRANSLATED VERSION OF THE SWEDISH RESEARCH UPDATE PUBLISHED ON 2 AUGUST)
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/